Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DAPT(Dual Antiplatelet Therapy)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT05650411
What this trial is testing

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Who this might be right for
Left Main Coronary Artery Stenosis
IGLESIAS Juan Fernando 828
Large-scale testing (Phase 3)Looking for participantsNCT03789916
What this trial is testing

SAPT Versus DAPT in Incomplete Revascularization After CABG

Who this might be right for
Coronary Artery Disease
Campus Bio-Medico University 800
Not applicableNot Yet RecruitingNCT07024446
What this trial is testing

Comparison of Cardiovascular Risks Between Hip Fracture Surgery With Continued DAPT（Dual Antiplatelet Therapy ） Within 6 Weeks vs After 6 Weeks Post-PCI（Percutaneous Coronary Intervention）: A Prospective Observational Cohort Study

Who this might be right for
PCI PatientsDAPT(Dual Antiplatelet Therapy)Hip Fracture Surgeries
Fujian Medical University Union Hospital 50
Not applicableUnknownNCT05770674
What this trial is testing

Comparison of 1 Month vs. 12 Months DAPT in Patients Undergoing PCI With Genoss® DES

Who this might be right for
Coronary Artery Disease
Kiyuk Chang 2,186
Not applicableStudy completedNCT03197298
What this trial is testing

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents
Thorax Centrum Twente 2,062
Large-scale testing (Phase 3)Looking for participantsNCT05997693
What this trial is testing

One-Month DAPT in CABG Patients

Who this might be right for
Chronic Coronary Disease
Weill Medical College of Cornell University 700
Not applicableNot Yet RecruitingNCT06648720
What this trial is testing

Efficacy and Safety of Shortening Dual Antiplatelet Therapy Duration with IVUS Guidance in PCI Patients

Who this might be right for
Coronary Arterial Disease (CAD)Percutaneous Coronary Intervention (PCI)Intravascular Ultrasound+1 more
University Medical Center Ho Chi Minh City (UMC) 3,566
Post-approval studies (Phase 4)Looking for participantsNCT06821191
What this trial is testing

Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study

Who this might be right for
Coronary Artery Disease
University of Florida 78
Not applicableStudy completedNCT03344653
What this trial is testing

Controlled Trial With Resolute Onyx in One Month Dual Antiplatelet Therapy (DAPT) for High-Bleeding Risk Patients

Who this might be right for
Coronary Artery Disease
Medtronic Vascular 2,000
Post-approval studies (Phase 4)Looking for participantsNCT05262803
What this trial is testing

Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction

Who this might be right for
Myocardial Infarction
Rikke Sorensen 2,808
Not applicableLooking for participantsNCT06075433
What this trial is testing

Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionDual Antiplatelet Therapy
Genoss Co., Ltd. 1,000
Post-approval studies (Phase 4)Looking for participantsNCT07007143
What this trial is testing

STrategies for Antithrombotic tReatment Following Transcatheter Edge-to-Edge Repair in Patients Without an Indication for Oral Anticoagulant

Who this might be right for
Mitral Regurgitation
Chinese Academy of Medical Sciences, Fuwai Hospital 1,032
Not applicableStudy completedNCT07480629
What this trial is testing

The 10-Year Extended Follow-up of the DACAB Trial

Who this might be right for
Coronary Artery DiseaseCABGAntiplatelet Therapy of Coronary Artery Bypass
Ruijin Hospital 500
Post-approval studies (Phase 4)Study completedNCT02605447
What this trial is testing

EVOLVE Short DAPT Study

Who this might be right for
Coronary Artery Disease
Boston Scientific Corporation 2,009
Not applicableUnknownNCT06241833
What this trial is testing

Emulation of Randomized Clinical Trial in Cardiovascular Disease

Who this might be right for
Myocardial InfarctionCoronary Artery Disease
Samsung Medical Center 118,420
Not applicableStudy completedNCT05476081
What this trial is testing

A REAl-life Study on Short-term DAPT in Patients With Ischemic Stroke or TIA

Who this might be right for
Ischemic StrokeTIA
University of L'Aquila 2,239
Not applicableStudy completedNCT03815175
What this trial is testing

XIENCE 28 USA Study

Who this might be right for
Bleeding DisorderIschemic StrokeHemorrhagic Stroke+6 more
Abbott Medical Devices 1,605
Not applicableLooking for participantsNCT06075420
What this trial is testing

Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease

Who this might be right for
Percutaneous Coronary InterventionDual Antiplatelet Therapy
Genoss Co., Ltd. 1,000
Not applicableLooking for participantsNCT03823547
What this trial is testing

Future Optimal Research and Care Evaluation

Who this might be right for
Acute Coronary SyndromeMyocardial Infarction
J.M. ten Berg 99,999
Large-scale testing (Phase 3)UnknownNCT05903976
What this trial is testing

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS

Who this might be right for
Dual Antiplatelet TherapyAcute Coronary SyndromeCoronary Artery Disease
Azienda Ospedaliera Universitaria Policlinico "G. Martino" 200
Next Page